230 related articles for article (PubMed ID: 16621191)
1. Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro.
Li A; Ojogho O; Franco E; Baron P; Iwaki Y; Escher A
Vaccine; 2006 Jun; 24(23):5036-46. PubMed ID: 16621191
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice.
Li AF; Hough J; Henderson D; Escher A
Vaccine; 2004 Apr; 22(13-14):1751-63. PubMed ID: 15068859
[TBL] [Abstract][Full Text] [Related]
3. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
4. A therapeutic DNA vaccination strategy for autoimmunity and transplantation.
Li A; Chen J; Hattori M; Franco E; Zuppan C; Ojogho O; Iwaki Y; Escher A
Vaccine; 2010 Feb; 28(8):1897-904. PubMed ID: 20188244
[TBL] [Abstract][Full Text] [Related]
5. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
7. Protective regulatory T cell generation in autoimmune diabetes by DNA covaccination with islet antigens and a selective CTLA-4 ligand.
Glinka Y; Chang Y; Prud'homme GJ
Mol Ther; 2006 Oct; 14(4):578-87. PubMed ID: 16790365
[TBL] [Abstract][Full Text] [Related]
8. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: a role for CD4+ regulatory T cells and TGF-beta?
Song L; Wang J; Wang R; Yu M; Sun Y; Han G; Li Y; Qian J; Scott DW; Kang Y; Soukhareva N; Shen B
Gene Ther; 2004 Oct; 11(20):1487-96. PubMed ID: 15343360
[TBL] [Abstract][Full Text] [Related]
9. The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.
Pop SM; Wong CP; He Q; Wang Y; Wallet MA; Goudy KS; Tisch R
Diabetes; 2007 May; 56(5):1395-402. PubMed ID: 17317763
[TBL] [Abstract][Full Text] [Related]
10. Regulatory CD8+ T cells induced by exposure to all-trans retinoic acid and TGF-beta suppress autoimmune diabetes.
Kishi M; Yasuda H; Abe Y; Sasaki H; Shimizu M; Arai T; Okumachi Y; Moriyama H; Hara K; Yokono K; Nagata M
Biochem Biophys Res Commun; 2010 Mar; 394(1):228-32. PubMed ID: 20206130
[TBL] [Abstract][Full Text] [Related]
11. IL-2 induces in vivo suppression by CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Brandenburg S; Takahashi T; de la Rosa M; Janke M; Karsten G; Muzzulini T; Orinska Z; Bulfone-Paus S; Scheffold A
Eur J Immunol; 2008 Jun; 38(6):1643-53. PubMed ID: 18493984
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of regulatory T-cell induction by antigen-IgG-transduced splenocytes.
Wang R; Song L; Han G; Wang J; Chen G; Xu R; Yu M; Qian J; Shen B; Li Y
Scand J Immunol; 2007 Nov; 66(5):515-22. PubMed ID: 17883389
[TBL] [Abstract][Full Text] [Related]
13. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions.
Sun JB; Cuburu N; Blomquist M; Li BL; Czerkinsky C; Holmgren J
Scand J Immunol; 2006 Sep; 64(3):251-9. PubMed ID: 16918694
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
15. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
[TBL] [Abstract][Full Text] [Related]
16. CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L
Novartis Found Symp; 2003; 252():279-86; discussion 286-90. PubMed ID: 14609225
[TBL] [Abstract][Full Text] [Related]
17. Administration of a determinant of preproinsulin can induce regulatory T cells and suppress anti-islet autoimmunity in NOD mice.
Arai T; Moriyama H; Shimizu M; Sasaki H; Kishi M; Okumachi Y; Yasuda H; Hara K; Yokono K; Nagata M
Clin Immunol; 2010 Jul; 136(1):74-82. PubMed ID: 20359955
[TBL] [Abstract][Full Text] [Related]
18. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1-induced CD4+CD25+ regulatory T cells in vitro reverse and prevent a murine lupus-like syndrome of chronic graft-versus-host disease.
Su H; Ye DQ; Wang BL; Fang XH; Chen J; Wang Q; Li WX; Zhang N
Br J Dermatol; 2008 Jun; 158(6):1197-209. PubMed ID: 18410422
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-7 is a survival factor for CD4+ CD25+ T-cells and is expressed by diabetes-suppressive dendritic cells.
Harnaha J; Machen J; Wright M; Lakomy R; Styche A; Trucco M; Makaroun S; Giannoukakis N
Diabetes; 2006 Jan; 55(1):158-70. PubMed ID: 16380489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
